Dyadic to present at h.c. wainwright 23rd annual global investment conference

Jupiter, fla., sept. 10, 2021 (globe newswire) -- dyadic international, inc. ("dyadic", "we", "us", "our", or the "company") (nasdaq:dyai), a global biotechnology company focused on further improving, applying, and deploying its proprietary c1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and therapeutics at flexible commercial scales, today announced that the company's management will be attending and presenting at the following upcoming virtual investor event:
DYAI Ratings Summary
DYAI Quant Ranking